Hikma Pharmaceuticals USA Inc., the U.S.-based business of Hikma Pharmaceuticals PLC, extended its previously announced recall of certain lots of pain and inflammation medication Ketorolac Tromethamine in the form of injection for the potential presence of small visible particulate matters.
from RTT - Biotech https://ift.tt/2IziAMg
via IFTTT
No comments:
Post a Comment